Topical Antibiotics for Minor Skin Infections
Mupirocin 2% ointment applied three times daily for 5-7 days is the first-line topical antibiotic for minor skin infections such as impetigo and secondarily infected wounds. 1, 2
First-Line Topical Treatment
- Mupirocin 2% ointment is the gold standard for localized impetigo and minor infected skin lesions (eczema, ulcers, lacerations), with clinical efficacy rates of 71-93% in controlled trials 1, 2
- Apply three times daily for 5-7 days to limited lesions 1, 2
- Retapamulin 1% ointment is an effective alternative if mupirocin is unavailable, applied twice daily for 5 days 2, 3
- Retapamulin is FDA-approved for impetigo in patients aged 9 months and older, covering up to 100 cm² in adults or 2% total body surface area in pediatric patients 3
Critical Agents to Avoid
- Do not use bacitracin or neomycin as they are considerably less effective than mupirocin or retapamulin 2
- While older literature suggests triple-antibiotic ointment (neomycin-bacitracin-polymyxin) has some efficacy 4, 5, 6, current guidelines prioritize mupirocin and retapamulin for superior effectiveness 1, 2
When to Escalate to Systemic Antibiotics
Topical therapy should only be used for limited, localized infections 1. Switch to oral antibiotics when:
- Multiple lesions or widespread infection is present 1
- Deeper tissue involvement is evident 1
- Systemic symptoms develop (fever, malaise, lymphadenopathy) 2
- No improvement after 48-72 hours of topical therapy 2
- High-risk patient factors exist: diabetes, immunosuppression 1
- High-risk anatomic locations are involved: face, hands, genitals 1
Systemic Antibiotic Selection (When Needed)
For Presumed MSSA:
- Dicloxacillin 250 mg four times daily for adults 2
- Cephalexin 250-500 mg four times daily as an alternative 2
For Suspected or Confirmed MRSA:
- Clindamycin 300-450 mg three times daily for adults 2
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily as an alternative 2
Pediatric Considerations
- Mupirocin 2% ointment remains first-line for children with minor skin infections 2
- Retapamulin is safe for children aged 9 months and older 3
- Avoid tetracyclines (doxycycline, minocycline) in children under 8 years due to tooth discoloration risk 2
- Do not use penicillin alone as it lacks adequate coverage against S. aureus 2
Important Pitfalls to Avoid
- Never use rifampin as monotherapy or adjunctive therapy for skin infections 2
- Topical antibiotics are not for systemic, mucosal, intranasal, ophthalmic, or intravaginal use 3
- Epistaxis has been reported with nasal mucosal application of retapamulin 3
- Discontinue topical therapy if severe local irritation or sensitization occurs 3